These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21415489)

  • 1. Cholera toxin - a foe & a friend.
    Sanchez J; Holmgren J
    Indian J Med Res; 2011 Feb; 133(2):153-63. PubMed ID: 21415489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholera toxin structure, gene regulation and pathophysiological and immunological aspects.
    Sánchez J; Holmgren J
    Cell Mol Life Sci; 2008 May; 65(9):1347-60. PubMed ID: 18278577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae.
    Lebens M; Terrinoni M; Karlsson SL; Larena M; Gustafsson-Hedberg T; Källgård S; Nygren E; Holmgren J
    Vaccine; 2016 Apr; 34(18):2121-8. PubMed ID: 26973069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
    Holmgren J; Adamsson J; Anjuère F; Clemens J; Czerkinsky C; Eriksson K; Flach CF; George-Chandy A; Harandi AM; Lebens M; Lehner T; Lindblad M; Nygren E; Raghavan S; Sanchez J; Stanford M; Sun JB; Svennerholm AM; Tengvall S
    Immunol Lett; 2005 Mar; 97(2):181-8. PubMed ID: 15752556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholera toxin B: one subunit with many pharmaceutical applications.
    Baldauf KJ; Royal JM; Hamorsky KT; Matoba N
    Toxins (Basel); 2015 Mar; 7(3):974-96. PubMed ID: 25802972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts.
    Daniell H; Lee SB; Panchal T; Wiebe PO
    J Mol Biol; 2001 Aug; 311(5):1001-9. PubMed ID: 11531335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholera immunology and the molecular biology of cholera toxin. Recent progress and future prospects].
    Carrada Bravo T
    Rev Alerg; 1993; 40(4):91-4. PubMed ID: 8143024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and secretion of cholera toxin B subunit in lactobacilli.
    Okuno T; Kashige N; Satho T; Irie K; Hiramatsu Y; Sharmin T; Fukumitsu Y; Uyeda S; Yamada S; Harakuni T; Miyata T; Arakawa T; Imoto M; Toda A; Nakashima Y; Miake F
    Biol Pharm Bull; 2013; 36(6):952-8. PubMed ID: 23727916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit.
    Rhie GE; Jung HM; Kim BS; Mekalanos JJ
    Vaccine; 2008 Oct; 26(43):5443-8. PubMed ID: 18582519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the possible role of ctxB7 allele on higher production of cholera toxin by Haitian variant Vibrio cholerae O1.
    Naha A; Mandal RS; Samanta P; Saha RN; Shaw S; Ghosh A; Chatterjee NS; Dutta P; Okamoto K; Dutta S; Mukhopadhyay AK
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008128. PubMed ID: 32236098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of cholera toxin subunit B binding to human large intestinal epithelium. An immunohistochemical study.
    Kirkeby S; Lynge Pedersen AM
    Microb Pathog; 2018 Nov; 124():332-336. PubMed ID: 30145256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pressure on refolding of recombinant pentameric cholera toxin B.
    Rodrigues D; Farinha-Arcieri LE; Ventura AM; Chura-Chambi RM; Malavasi NV; Lemke LS; Guimarães JS; Ho PL; Morganti L
    J Biotechnol; 2014 Mar; 173():98-105. PubMed ID: 24445168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
    Häse CC; Thai LS; Boesman-Finkelstein M; Mar VL; Burnette WN; Kaslow HR; Stevens LA; Moss J; Finkelstein RA
    Infect Immun; 1994 Aug; 62(8):3051-7. PubMed ID: 8039872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Chicken Egg Yolk Antibody (IgY) Against Recombinant Cholera Toxin B Subunit and Evaluation of Its Prophylaxis Potency in Mice.
    Barati B; Ebrahimi F; Nazarian S
    Iran J Immunol; 2018 Mar; 15(1):47-58. PubMed ID: 29549232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholera: pathophysiology and emerging therapeutic targets.
    Muanprasat C; Chatsudthipong V
    Future Med Chem; 2013 May; 5(7):781-98. PubMed ID: 23651092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The immunology of cholera and the molecular biology of cholera toxin. Recent progress and future perspectives].
    Carrada-Bravo T
    Rev Alerg Mex; 1994; 41(3):69-76. PubMed ID: 9377108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
    Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
    Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.